A prospective, randomized trial to compare effectiveness of intravitreal ziv-aflibercept to intravitreal bevacizumab in patients undergoing pars plana vitrectomy (PPV) for severe manifestations of diabetic retinopathy
Latest Information Update: 25 Jun 2020
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 25 Jun 2020 New trial record